| Trial ID: | L0746 |
| Source ID: | ChiCTR1900023153
|
| Associated Drug: |
Propofol tenofovir
|
| Title: |
Efficacy and safety of propofol tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Chronic viral hepatitis B with nonalcoholic fatty liver disease
|
| Interventions: |
CHB with NAFLD group + CHB without NAFLD group:Propofol Tenofovir;
|
| Outcome Measures: |
HBV DNAInhibition rate;renal function;Osteoporosis;ALT recurrence rate;Liver hardness;
|
| Sponsor/Collaborators: |
Jinyu Xia
|
| Gender: |
All
|
| Age: |
1860
|
| Phases: |
Phase 4
|
| Enrollment: |
CHB with NAFLD group + CHB without NAFLD group:1000;
|
| Study Type: |
Basic Science
|
| Study Designs: |
Factorial
|
| Start Date: |
14/05/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
20 May 2019
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=38808
|
